GlassScriptPhysician profile
Ivan Peter Harnden
NPI 1568781706
$5,957.76
in general payments reported to CMS, 2019-2025
33 companies · $271 in 2025
The $271 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,883 · 2020: $376 · 2021: $307 · 2022: $113 · 2023: $678 · 2024: $2,330 · 2025: $271.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,852 · Travel and Lodging: $1,428.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,851.54 |
| Travel and Lodging | $1,427.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,416.57 | 2023-2025 | Axios, Exalt Model D, Overstitch Endoscopic Suturing System |
| Apollo Endosurgery US INC | $778.33 | 2019-2023 | Overstitch Endoscopic Suturing System |
| Abbvie INC. | $678.90 | 2019-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $344.32 | 2019-2021 | |
| Lundbeck LLC | $169.73 | 2022-2023 | Vyepti |
| Pfizer INC. | $151.85 | 2019-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $146.02 | 2019-2020 | |
| Myriad Women'S Health, INC. | $130.50 | 2023 | Myrisk |
| Bone Support INC. | $127.36 | 2024 | Ceramentbone Void Filler, Cerament G |
| Ethicon US, LLC | $112.80 | 2023-2025 | Vistaseal, Surgicel Nu-Knit, Echelon Flex |
| Qol Medical, LLC | $88.89 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $88.15 | 2019-2021 | |
| Aspire Bariatrics, INC. | $72.69 | 2019 | |
| Olympus America INC. | $62.32 | 2023 | Hanarostent Lowaxtm Duodenum/Pylorus(Nnn) |
| Janssen Biotech, INC. | $59.82 | 2019-2021 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sk Life Science, INC. | $51.29 | 2022-2023 | |
| Ucb, INC. | $48.47 | 2020-2023 | Briviact |
| Eisai INC. | $46.73 | 2023 | |
| Medtronic, INC. | $44.57 | 2024-2025 | Gi Genius, Endoflip |
| Lilly USA, LLC | $42.82 | 2022-2023 | Emgality, Reyvow |
| Celgene Corporation | $40.36 | 2021 | |
| Merck Sharp & Dohme LLC | $33.29 | 2019 | |
| Catalyst Pharmaceuticals, INC. | $28.56 | 2023 | Fycompa |
| Gilead Sciences, INC. | $27.53 | 2023 | |
| Daiichi Sankyo INC. | $23.85 | 2019 | |
| Ironwood Pharmaceuticals, INC | $23.23 | 2019-2020 | |
| Shire North American Group INC | $22.52 | 2019 | |
| Upsher-Smith Laboratories LLC | $20.54 | 2022 | |
| Shionogi INC | $19.06 | 2020 | |
| Endo Pharmaceuticals INC. | $17.23 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $16.43 | 2019 | |
| Alfasigma USA, INC. | $15.69 | 2020 | |
| Endogastric Solutions, INC | $7.34 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ivan Harnden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.